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Abstract
The efficacy of microfracture (MF), mosaicplasty (MO), 
and autologous chondrocyte implantation (ACI) tech-
niques are still a matter of debate. This review aims to 
analyze comparative studies of these techniques, review 
the results of no treatment, and the natural history of 
untreated articular cartilage lesions. 
   A PubMed search on the topic was performed. The 
most important (14) articles, as judged by the author, 
were selected for this review.
   There is limited evidence that any intervention sig-
nificantly alters the natural history of these lesions and 
there is no evidence of significant difference between 
ACI and MF and MO. Paramount for successful surgical 
cartilage repair is a stable knee with a well-aligned lower 
limb. There is insufficient evidence at present to say that 
ACI is cost-effective, compared with MF or MO. 
T reatments for managing full thickness articular cartilage defects of the knee, including micro-fracture (MF) and mosaicplasty (MO), are not always effective. When they are, long-term ben-
efits may not be maintained and osteoarthritis may 
develop.1,2 An alternative is autologous chondrocyte 
implantation (ACI), the surgical implantation of healthy 
cartilage cells into the damaged areas. In other words, 
various treatment modalities for deep cartilage defects are 
currently available.3-8 The efficacy of MF, MO, and ACI 
techniques is still a matter of debate. 
The purpose of this review was to: 1) clarify whether 
there is a difference between ACI, MO, and MF regard-
ing their results; 2) review the results of no treatment 
and compare this control group to the treatment group 
(ie, what is the natural history of untreated small articu-
lar cartilage lesions?); 3) analyze the role of continuous 
passive motion (CPM) after the surgical treatment 
of cartilage defects; 4) review the role of magnetic 
resonance imaging (MRI) in the assessment of cartilage 
defects; and 5) define whether ACI is a cost-effective 
procedure.
Methods
A PubMed search was performed using the following key 
words: cartilage lesion, knee, natural history, ACI, micro-
fracture, mosaicplasty. The most important (14) articles, 
as judged by the author, were selected for this review. The 
main criterion for selection was that the articles addressed 
and provided solutions to the questions of this article.
Results
Only 14 articles were reviewed on the topic of cartilage 
lesions, knee, natural history, ACI, MO, and MF. Some 
of them were comparative studies. Other studies also ana-
lyzed the natural history of knee cartilage lesions, the role 
of CPM in the postoperative period of the surgical proce-
dure, the role of the MRI, and a comparison between the 
cost-effectiveness of ACI, MO, and MF.
Natural History of Knee Cartilage Lesions
The natural history of cartilage lesions in the knee joint 
has been investigated in the literature by means of experi-
mental and clinical studies.
  
Experimental Studies on Osteochondral Defects. In an 
experimental study on osteochondral defects, Albrecht 
and colleagues3 did not find hyaline cartilage histologically 
in osteochondral defects left untreated. In their study, 75 
knee joints in 46 adult rabbits with osteochondral defects 
of 4 mm diameter were placed by a drill reaching the 
cancellous bone. Twenty-three defects were left untreated, 
closed by collagen foam or fibrin adhesive, or a combina-
tion of both. Fifty-two defects were closed with very small 
autologous cartilage fragments and a special fibrin adhe-
sive. In the first group of 23 joints, which were observed 
for up to 40 weeks, no hyaline cartilage was found histo-
logically in any of the defects. In the second group, a rapid 
proliferation of chondrocytes appeared with development 
of hyaline cartilage with alcianblue-positive matrix. It 
resembled juvenile cartilage in its histologic appearance 
and with regard to the induction of ossification. 
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In another experimental study, Burks and colleagues4 
compared untreated or bone-grafted defects with osteo-
chondral allografts. Their hypothesis was that small 
osteochondral autograft plug placed in the center of a 
large defect in a sheep femoral condyle would be supe-
rior to either an untreated or a bone-grafted defect. The 
main conclusion of the study was that osteochondral 
autograft plugs may be able to treat larger articular 
lesions without complete fill of the defect.
Clinical Studies on Ostechondritis Dissecans. De Smet and 
colleagues5 investigated the usefulness of plain film and 
MRI findings in predicting the outcome of conservatively 
treated patients with femoral juvenile osteochondritis 
dissecans (JOCD). Without knowledge of the clinical 
outcome, they retrospectively reviewed the initial plain 
films and MRI examinations. The main conclusion was 
that it appears that a good clinical outcome is likely when 
the femoral growth plate is open, when the JOCD is small, 
and when the lesion is stable by MRI. When an articular 
defect is found on an MRI, the patient is likely to have a 
poor outcome.
According to Polousky,6 despite our long recognition 
of JOCD, the natural history and most effective thera-
pies are poorly understood. Treatment decisions must 
be based on the stability of the lesion. Stable JOCD 
lesions should be treated initially with activity modifi-
cation and possibly, immobilization. Unstable lesions 
and stable lesions not responding to an initial course 
of nonoperative therapy should be surgically treated. 
Surgical treatment must be based on the radiographic 
and arthroscopic characteristics of the lesion. Multiple 
techniques from simple arthroscopic drilling and fixa-
tion to salvage techniques for cartilage restoration can 
be used.
Clinical Studies on Articular Cartilage Defects.  Widuchowski 
and colleagues7 stated that the potential candidates for 
cartilage repair surgery are patients with 1 to 3 localized 
Outerbridge grade III and IV cartilage lesions. However, 
because these patients are a heterogeneous group, and the 
natural history of cartilage lesions remains unknown, the 
total number of patients who might benefit from cartilage 
repair also remains unknown.
According to Safran and Seiber,8 the complex struc-
ture and biomechanical function of articular carti-
lage make chondral injuries a management challenge. 
Articular cartilage has limited, if  any, capacity to heal 
and/or regenerate. Although the natural history of 
articular cartilage lesions has not been clearly studied, 
significant injuries are believed to progress, resulting in 
degenerative arthritis of the joint. Changes have been 
made in surgical techniques in an attempt to better treat 
these lesions. However, there is limited evidence that any 
surgical procedure significantly alters the natural histo-
ry of these lesions. Randomized trials have been done to 
examine the results of common restoration procedures 
performed today, such as MF, MO, and ACI. Because 
the natural history of articular cartilage lesions has not 
been defined, we can evaluate the utility of surgical 
interventions only by comparing methods.
Comparative Studies
Wasiak and colleagues9 determined the effectiveness of 
ACI in people with full thickness articular cartilage defects 
of the knee. In their report, they included 4 randomized 
controlled trials. One trial of ACI versus MO showed sta-
tistically significant results for ACI at 1 year, but only in 
a post hoc subgroup analysis of participants with medial 
condylar defects; 88% had excellent or good results with 
ACI versus 69% with MO. A second trial of ACI versus 
MO showed no statistically significant difference in clini-
cal outcomes at 2 years. There was no statistically signifi-
cant difference in results at 2 years in a trial comparing 
ACI with MF. In addition, 1 trial of matrix-guided ACI 
versus MF did not have enough long-term results to reach 
definitive conclusions. The main conclusion of the study 
was that there is, at present, no evidence of significant dif-
ference between ACI, MF, and MO. 
Vasiliadis and Wasiak10 evaluated the Cochrane Bone, 
Joint and Muscle Trauma Group Specialized Register, 
the Cochrane Central Register of Controlled Trials, 
MEDLINE, EMBASE, SPORTDiscus, the WHO 
International Clinical Trials Registry Platform, and 
Current Controlled Trials. They sought to determine the 
efficacy and safety of ACI in patients with full thickness 
articular cartilage defects of the knee. The selection 
criteria were randomized and quasi-randomized trials 
comparing ACI with any other type of treatment (eg, 
no treatment or placebo) for symptomatic cartilage 
defects of the medial or lateral femoral condyle, femoral 
trochlea, or patella. Six heterogeneous trials were iden-
tified. Three trials compared ACI versus mosaicplasty. 
One showed statistically significant results in favor of 
ACI at 1 year in the number of people with ‘good’ or 
‘excellent’ functional results. Conversely, another trial 
found significant improvement for the MO group when 
evaluated using one functional scoring system at 2 years, 
but no statistically significant differences based on 2 
other scoring systems. A third trial showed no difference 
between ACI and MO, 10 months on average after the 
surgery. There was no statistically significant difference 
in functional results at 2 years in single trials comparing 
ACI with MF or characterized chondrocyte implanta-
tion versus MF. The results of the sixth trial compar-
ing matrix-guided ACI with MF were undermined by 
the great loss to follow-up. Vasiliadis and Wasiak10 
concluded that there is insufficient evidence to reach 
conclusions on the use of ACI for treating full thickness 
articular cartilage defects in the knee. Further good 
quality randomized controlled studies with long-term 
functional outcomes are needed, they added.
Data on clinical effectiveness was obtained by Clar 
and colleagues11 from randomized trials, supplemented 
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by data from selected observational studies for longer 
term results, and for the natural history of  chondral 
lesions. Due to a lack of  long-term results such as later 
osteoarthritis and total knee replacement, only illus-
trative modeling was done, using some assumptions 
that seemed reasonable, but were not evidence-based. 
Four randomized controlled trials were included, as 
well as observational data from case series. Two stud-
ies compared ACI with MO, the third compared ACI 
with MF, and the fourth compared matrix-guided ACI 
(MACI) with MF. Follow-up was 1 year in 1 study and 
up to 3 years in the remaining 3 studies. The first trial 
of  ACI versus MO showed that ACI gave better results 
than MO at 1 year. Overall, 88% had excellent or good 
results with ACI versus 69% with MO. About half  of 
the biopsies after ACI showed hyaline cartilage. The 
second trial of  ACI versus MO found little difference 
in clinical results at 2 years. Biopsies from the ACI 
group showed fibrocartilage rather than hyaline carti-
lage. The trial of  ACI versus MF also found only small 
differences in outcomes at 2 years. Finally, the trial of 
MACI versus MF contained insufficient long-term 
results, but the study showed the feasibility of  doing 
ACI by the MACI technique. It also suggested that 
after ACI, it takes 2 years for full-thickness cartilage 
to be produced. 
According to Pietsch and Hofmann,12 several treat-
ment modalities for the osteoarthritis of the knee in 
middle-aged patients to preserve the joint are available. 
They reported good and excellent results with MF at a 
follow-up of 2 years. They stated that cartilage defects 
up to 4 cm2 should be treated by the mosaic-type osteo-
chondral autologous transplantation. ACI should be 
considered when larger defects are presented in younger 
patients. In existing osteoarthritis, ACI is not recom-
mended. They concluded that up until now, there is no 
significant difference in results between ACI, MO, and 
MF. The basis for successful surgical cartilage repair is 
a stable knee with a well-aligned lower limb. If  the lower 
limb is misaligned, an alignment additional osteotomy 
of the knee should be considered.
The Role of Continuous Passive  
Motion Postoperatively
Fazalare and colleagues13 evaluated the clinical evidence 
of using CPM postoperatively after treating articular 
cartilage lesions of the knee. Multiple medical databases 
were searched. No randomized controlled studies were 
identified. A meta-analysis could not be carried out as a 
result of the heterogeneity of the procedures and outcome 
measures. They stated that conclusions regarding the 
benefits of CPM postoperatively in knee cartilage surgery 
could not be made secondary to this heterogeneity. Also, 
that the clinical evidence to support the use of CPM is 
lacking despite the common clinical practice of CPM 
implementation postoperatively in knee cartilage restora-
tion procedures. 
Magnetic Resonance Imaging in the  
Assessment of Cartilage Repair
Domayer and colleagues14 reviewed the clinical aspects 
of MF, MO, and ACI and reported the recent technical 
advances that have improved MRI of cartilage. They rec-
ommended morphological evaluation methods for each of 
the respective techniques. Finally, they provided an over-
view of T2 mapping and delayed gadolinium-enhanced 
MRI of cartilage in cartilage repair. The introduction of 
high-field MRI to clinical routine makes high resolution 
and three-dimensional imaging readily available. 
Cost-Effectiveness of Different Treatments 
Clar and colleagues11 reported the current cost-effective-
ness evidence on ACI. Economic models, using some 
assumptions about long-term outcomes that seem reason-
able, suggested that ACI would be cost-effective because it 
is more likely to produce hyaline cartilage, which is more 
likely to be durable and to prevent osteoarthritis in the 
longer term. However, they concluded that there is insuf-
ficient evidence at present to say that ACI is cost-effective 
compared with MF or MO. 
discussion
This review has tried to address the following questions: 
1) Is there a difference between ACI, MO, and MF regard-
ing their results; 2) review the results of no treatment, 
compared with the treatment group (ie, what is the natural 
history of untreated small articular cartilage lesions); 3) 
What is the role of CPM after the surgical treatment of 
cartilage defects (ie, postoperatively); 4) What is the role 
of MRI in the assessment of cartilage defects; and 5) Is 
ACI cost-effective, compared with MF and MO.
In regard to the results of ACI, MF, and MO in 
patients with full thickness articular cartilage defects of 
the knee, this review has shown that there is insufficient 
evidence to reach conclusions on the use of ACI for treat-
ing full thickness articular cartilage defects in the knee.10
Although the natural history of articular cartilage 
lesions has not been clearly studied, significant injuries 
are believed to progress, resulting in degenerative arthri-
tis of the joint.8 Changes have been made in surgical 
techniques in an attempt to better manage these lesions. 
However, there is limited evidence that any surgical 
intervention significantly alters the natural history of 
these lesions. Randomized trials have been done to 
examine the outcomes of common restoration proce-
dures performed, such as MF, MO, and ACI. Because 
the natural history of articular cartilage lesions has not 
been defined, we can assess the utility of surgical inter-
ventions only by comparing methods.
The clinical evidence to support the use of CPM is 
lacking despite an overwhelming abundance of basic 
science support and the common clinical practice of 
CPM implementation postoperatively in knee cartilage 
restoration procedures.13 Thus, the role of CPM after 
surgery is still unknown.
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New quantitative MRI techniques that directly visu-
alize the molecular structure of cartilage may further 
advance our understanding of cartilage repair.14 The 
clinical evaluation of cartilage repair tissue is a complex 
issue, and MRIs are becoming increasingly important 
both in research and in clinical routine. Finally, there is 
insufficient evidence, at present, to say that ACI is cost-
effective compared with MF or MO.11 
In conclusion, the natural history of cartilage lesions 
remains so far unknown. There is, at present, no evi-
dence of significant difference between ACI and MF 
and MO. Therefore, further good quality randomized 
controlled trials with long-term functional outcomes 
are required. However, based on the data reviewed, the 
results may be similar and it is possible that none of the 
treatment methods that purport to “restore” articular 
cartilage are effective.
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  Quick Poll                                          ?
      Submit your answer at www.amjorthopedics.com
What technique do you prefer for the treatment of  
cartilage defects in the knee joint?
m A. Microfracture
m B. Mosaicplasty
m C. Autologous chondrocyte implantation
m D. Other
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